Ireland’s economy grew three times as rapidly as first estimated in the first quarter. That was driven by stockpiling of ...

Gene therapies, exon-skipping drugs and next-gen steroids are reshaping Duchenne muscular dystrophy care, targeting broader ages and mutations. We are witnessing the fastest pivot in rare-disease ...

The digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030. The growth ...

When it rebranded as WW, it looked like the writing was on the wall for WeightWatchers. BBD Perfect Storm Health’s Nick ...

Meanwhile, the MHRA has also warned all people seeking treatment with the so-called "skinny jabs" to beware of counterfeit ...

Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

With volatility begetting opportunity, here are all six stocks I've bought through the first five months of 2025. Image ...

A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...

Millions of Americans face the difficult decision of choosing between their health and their finances. Prescription ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Atherosclerosis Market Atherosclerosis Market Forecasted to Expand from USD 47.6 Billion in 2025 to USD 62.2 Billion by 2035 From m ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.